Italy · Delayed Price · Currency is EUR Philogen Statistics
Total Valuation
Philogen has a market cap or net worth of EUR 871.38 million. The enterprise value is 545.67 million.
| Market Cap | 871.38M |
| Enterprise Value | 545.67M |
Important Dates
The last earnings date was Wednesday, September 23, 2026.
| Earnings Date | Sep 23, 2026 |
| Ex-Dividend Date | May 18, 2026 |
Share Statistics
Philogen has 40.25 million shares outstanding. The number of shares has increased by 0.46% in one year.
| Current Share Class | 28.88M |
| Shares Outstanding | 40.25M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.79% |
| Float | 10.71M |
Valuation Ratios
The trailing PE ratio is 3.82 and the forward PE ratio is 106.04.
| PE Ratio | 3.82 |
| Forward PE | 106.04 |
| PS Ratio | 2.71 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | 3.26 |
| P/OCF Ratio | 3.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.09, with an EV/FCF ratio of 2.02.
| EV / Earnings | 2.35 |
| EV / Sales | 1.68 |
| EV / EBITDA | 2.09 |
| EV / EBIT | 2.12 |
| EV / FCF | 2.02 |
Financial Position
The company has a current ratio of 6.99, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.99 |
| Quick Ratio | 6.92 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.04 |
| Interest Coverage | 760.55 |
Financial Efficiency
Return on equity (ROE) is 98.35% and return on invested capital (ROIC) is 3,674.55%.
| Return on Equity (ROE) | 98.35% |
| Return on Assets (ROA) | 56.20% |
| Return on Invested Capital (ROIC) | 3,674.55% |
| Return on Capital Employed (ROCE) | 72.37% |
| Weighted Average Cost of Capital (WACC) | 4.04% |
| Revenue Per Employee | 1.37M |
| Profits Per Employee | 978,165 |
| Employee Count | 230 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 11.19 |
Taxes
In the past 12 months, Philogen has paid 30.01 million in taxes.
| Income Tax | 30.01M |
| Effective Tax Rate | 11.77% |
Stock Price Statistics
The stock price has decreased by -6.28% in the last 52 weeks. The beta is -0.03, so Philogen's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -6.28% |
| 50-Day Moving Average | 22.95 |
| 200-Day Moving Average | 22.50 |
| Relative Strength Index (RSI) | 40.79 |
| Average Volume (20 Days) | 21,242 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Philogen had revenue of EUR 315.27 million and earned 224.98 million in profits. Earnings per share was 5.57.
| Revenue | 315.27M |
| Gross Profit | 274.87M |
| Operating Income | 249.46M |
| Pretax Income | 254.99M |
| Net Income | 224.98M |
| EBITDA | 252.81M |
| EBIT | 249.46M |
| Earnings Per Share (EPS) | 5.57 |
Balance Sheet
The company has 337.14 million in cash and 11.44 million in debt, with a net cash position of 325.70 million or 8.09 per share.
| Cash & Cash Equivalents | 337.14M |
| Total Debt | 11.44M |
| Net Cash | 325.70M |
| Net Cash Per Share | 8.09 |
| Equity (Book Value) | 331.69M |
| Book Value Per Share | 8.24 |
| Working Capital | 304.25M |
Cash Flow
In the last 12 months, operating cash flow was 264.45 million and capital expenditures -2.04 million, giving a free cash flow of 262.41 million.
| Operating Cash Flow | 264.45M |
| Capital Expenditures | -2.04M |
| Depreciation & Amortization | 3.35M |
| Net Borrowing | -1.43M |
| Free Cash Flow | 262.41M |
| FCF Per Share | 6.52 |
Margins
Gross margin is 87.19%, with operating and profit margins of 79.13% and 71.36%.
| Gross Margin | 87.19% |
| Operating Margin | 79.13% |
| Pretax Margin | 80.88% |
| Profit Margin | 71.36% |
| EBITDA Margin | 80.19% |
| EBIT Margin | 79.13% |
| FCF Margin | 83.23% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 3.23%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 3.23% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 12.52% |
| FCF Payout Ratio | 10.74% |
| Buyback Yield | -0.46% |
| Shareholder Yield | 2.80% |
| Earnings Yield | 26.30% |
| FCF Yield | 30.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Philogen is 28.33, which is 30.86% higher than the current price. The consensus rating is "Buy".
| Price Target | 28.33 |
| Price Target Difference | 30.86% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -36.58% |
| EPS Growth Forecast (3Y) | -66.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Philogen has an Altman Z-Score of 12.25 and a Piotroski F-Score of 7.
| Altman Z-Score | 12.25 |
| Piotroski F-Score | 7 |